Targeted molecular imaging probe and method for in vivo molecular imaging
US9764048B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Inventors
Key dates
| Filing date | Jul 30, 2012 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jul 30, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/223
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a targeted molecular imaging probe consisting of a signal component, a component with a targeted affinity to Cx43 and a linker. The biochemical variation characteristic of connexin43 (Cx43) associated with cardiovascular diseases (especially arrhythmia) and neoplastic diseases can be reflected in the form of an image by using the targeted molecular imaging probe capable of being detected by an imaging device, to achieve in vivo molecular imaging.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.